JT002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JT002, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults [Phase 2]